Effects of clomiphene and tamoxifen on pregnancy rate in infertile wome
Phase 2
- Conditions
- Ovarian dysfunction, unspecified.Ovarian dysfunction, unspecified
- Registration Number
- IRCT201206131306N3
- Lead Sponsor
- Vice chancellor for research-Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 144
Inclusion Criteria
Inclusion criterion: infertile women with ovulation disorders without other cause of infertility. Exclusion criteria: abnormal semen analysis and HSG or laparoscopy; age over 40; myoma; hyperprolactinema; FSH over12; hypothyroidism; hyperthyroidism; previous history of induction of ovulation; renal & liver disease and contraindication of clomiphen citrate and tamoxifen.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy rate. Timepoint: End of menstural cycle. Method of measurement: Serum BhCG.
- Secondary Outcome Measures
Name Time Method Abortion rate. Timepoint: End of menstrual cycle. Method of measurement: The incidence of menstrual bleeding and new.;Multigestation rate. Timepoint: End of menstrual cycle. Method of measurement: Sonography.;Ovarian hyperstimulation syndrome. Timepoint: End of menstrual cycle. Method of measurement: Clinical and ultrasound.;Side effects such as headaches, dizziness, blurred vision, nausea and vomiting. Timepoint: During the treatment cycle. Method of measurement: Ask the patient.